MEXICO IN-VITRO DIAGNOSTICS MARKET ANALYSIS

Mexico In-Vitro Diagnostics Market, By Technique (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics, Hematology, and Other Techniques), By Product (Instrument, Reagent, and Other Products), By Usability (Disposable IVD Devices and Reusable IVD Devices), By Application (Infectious Diseases, Cancer/Oncology, Cardiology, Autoimmune Disease, Diabetes Nephrology, and Other Applications), and By End User (Diagnostic laboratories, Hospitals and Clinics, and Other End Users) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Published In : Jun 2022
Code : CMI5049
Pages :169
Formats :
Excel and PDF
Industry : Clinical Diagnostic

Market News

Recent Developments:

In 2021, Bio-Rad Laboratories, Inc. announced the launch of the CFX Opus 96 Dx System and the CFX Opus 384 Dx System, real-time PCR detection systems that have been listed with the U.S. FDA for IVD testing and that meet CE-IVD requirement for IVD use in Europe.

In 2020, Biomerieux SA launched three complementary molecular biology tests in ARGENE and BIOFIRE ranges to detect active SARS-CoV-2 infections, as well as two serology tests in the VIDAS immunoassay range to confirm the presence of antibodies in patients.